Pfizer and BioNTech said Friday that the immune responses against Omicron BA.4/BA.5 subvariants were “substantially higher” in people who got its new bivalent booster compared with people who ...

Pfizer and its German partner, BioNTech, announced Friday that their updated coronavirus booster shot targeting the omicron variant succeeded in strengthening the body’s army of disease-fighting ...

Pfizer and its collaborator BioNTech have shown that their new COVID-19 booster does what they hoped it would, with the same safety and side effect profile as earlier shots. In a study released ...

The updated mRNA boosters (from Pfizer and Moderna) are authorized by the FDA for adults who've gone at least two months since their last vaccine dose, whether it was a booster shot or a primary ...

Nearly two-thirds of the people in the US who’ve gotten an updated booster – 32 million – have gotten Pfizer, compared with about 18 million Moderna shots.

By Sharon LaFraniere WASHINGTON — A new study by Pfizer and BioNTech suggests that their updated coronavirus booster is better than its predecessor at increasing the antibody levels of people ...

The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 vaccine bivalent for children six months old through four years of age. At least ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC ...

Tuesday, Valneva SE (NASDAQ:VALN) and Pfizer Inc. (NYSE:PFE) released immunogenicity and safety data from their VLA15-221 Phase 2 study following a second booster vaccination of their Lyme disease ...

A Pfizer Covid booster vaccination gave a fit 54-year-old chronic pain, NHS doctors found. Larry Lowe, from Omagh in Northern ...